Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
about
Oral microbiota and cancerVironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6AEpstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyCo-infections and Pathogenesis of KSHV-Associated MalignanciesKaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of InfectionHost and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phaseAnti-heparan sulfate peptides that block herpes simplex virus infection in vivo.Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latencyViral latency and its regulation: lessons from the gamma-herpesviruses.Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoterHuman Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaHerpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirusHHV-8 infection: a model for reactivation and transmission.Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion.Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cellsThe HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitroMechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationMolecular biology of KSHV lytic reactivation.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirusIn vivo activation of toll-like receptor-9 induces an age-dependent abortive lytic cycle reactivation of murine gammaherpesvirus-68.Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects.Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.Correlation between infections with different genotypes of human cytomegalovirus and Epstein-Barr virus in subgingival samples and periodontal status of patientsProfessional antigen presenting cells in human herpesvirus 8 infection.Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declinValganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes.
P2860
Q24605400-E12FF5C6-5AF4-44BA-8CAB-7109160FB25BQ24607716-E8628C08-8E4C-4930-8E7C-D72884E9AD65Q24798984-7354BEEB-5C86-4016-AEBB-42985C7B6FBFQ26752599-69A222F7-FDCF-45CA-81D7-93750C0C35CFQ26766493-71AF0C54-3DBC-40A8-839F-80966D46A66BQ27487405-A442A363-4B6E-41C7-9ED6-4BB29E14143CQ31156919-A9B62F4F-80DD-47F2-B5A6-97CA51FD7F04Q33560572-EAE29167-F63A-46B9-AE6A-39FFB7C84C0DQ33761091-3FA136C6-020C-4E1E-A08A-1060B5625691Q33781299-D68F0423-75C7-49CF-83BF-01F364B916F0Q33906507-1B49ECF1-A362-4D7F-B774-9A653A9D7579Q33916507-61579DCE-E799-4283-B90B-3DD2AA8A6AC6Q34039189-FEC0C3E9-DD86-446C-843D-815C4F05F3AAQ34045753-BD3DDF04-7C56-484D-B621-2CF42D6B0FEEQ34130226-469A78A4-09EE-4DE4-A6A9-644CC5AB7C4DQ34162920-35E31AF4-A192-4343-9062-D9C4EF36F519Q34351693-6CF7ED7B-8CEB-4272-9873-6C1C2AD06FCCQ34490261-6A3F2A27-8087-4316-AAD2-4FCF8E4871E0Q34589617-4455A4EA-C33B-4A96-99B1-AC880F229CA2Q34615002-71FD32A1-E3AF-4C26-A63B-CC23D11CB420Q34627227-AAD01A07-6727-4E2C-B8DF-49066D004CFDQ34998791-ECDAE756-ECB3-4301-B062-22868FA00BECQ35000871-4B106BB0-2CD7-4C78-8629-07FF079A5A27Q35005190-CDE2EC42-B5BF-4A4C-8FF6-CB01ACBBF2C0Q35010647-EE72C7AD-8BBA-42CF-B081-7087D7A31053Q35014918-280750CA-E8A1-42A4-8A26-BF46B1084398Q35026060-859718EB-4AFB-4C8E-B9C2-7903D258D5FFQ35083522-B9D5FFEA-36D6-4D1C-A4DC-6810345C5806Q35102006-ECC1829B-F3EA-47D3-BE27-92EEA41387CEQ35168476-CE030EC3-4E14-449E-B35C-71A27556892FQ35550033-C9703AC4-EC19-40D4-9F68-3368A520C955Q35784760-03FBD08B-38BB-4D28-81F7-F5DBA86570A3Q35885525-F4A13BC6-0672-4675-86BA-FF34B5B4F63AQ36154559-8F94D2FE-E78A-4CC9-8482-CEF904BA25C1Q36167973-0783AC75-1E4B-4587-9876-18644BBF1C77Q36314432-23A2E980-5752-4D63-B38A-6C43027585BAQ36546999-D479FF5F-8512-41E4-B12C-E8A9E074477EQ37010247-343DE812-10B3-475B-98C8-DEB0E852CD7DQ37237122-999B7826-55AF-45B2-B521-F927B615D616Q37461513-9CE6061A-4488-41FA-9BBE-5E632D1E526C
P2860
Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Activation of Kaposi's sarcoma ...... tion by human cytomegalovirus.
@en
Activation of Kaposi's sarcoma-associated herpesvirus
@nl
type
label
Activation of Kaposi's sarcoma ...... tion by human cytomegalovirus.
@en
Activation of Kaposi's sarcoma-associated herpesvirus
@nl
prefLabel
Activation of Kaposi's sarcoma ...... tion by human cytomegalovirus.
@en
Activation of Kaposi's sarcoma-associated herpesvirus
@nl
P2093
P2860
P1433
P1476
Activation of Kaposi's sarcoma ...... tion by human cytomegalovirus.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.3.1378-1386.2001
P407
P577
2001-02-01T00:00:00Z